StratDeck

Two stocks in Medical Instruments & Supplies

Alcon vs Gerresheimer: profit, growth, debt and price compared

Alcon is stronger on 4 of 6 figures: profit margin, sales growth, debt and analysts' view. Gerresheimer is stronger on 2: price for its expected profit and price trend.

Figures as of 18 November 2026Yahoo Finance
Explore Alcon's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Alcon and Gerresheimer side by side
AlconALC.SWGerresheimerGXI.DE
Net marginStronger: 6.1%−17.5%
Revenue growth, past yearStronger: +4.70%−0.80%
Debt to equityStronger: 24.6%236.7%
Forward P/E17.3×Stronger: 13.5×
Dividend yield0.45%—
AnalystsStronger: Buy · 17Hold · 12
From its 200-day average+7.2%Stronger: +13.7%

Share price over the past year

  • Alcon+2.4%
  • Gerresheimer+40.9%

20 Nov 202518 Nov 2026

Alcon or Gerresheimer: which is stronger?

  • ALC.SW

    Which is more profitable?

    Alcon keeps more of each sale as profit: 6.1% against −17.5%.

  • ALC.SW

    Which is growing its sales faster?

    Alcon is growing its sales faster: +4.70% over the past year, against −0.80%.

  • ALC.SW

    Which has borrowed less?

    Alcon has borrowed less: its debt is 24.6% of what its shareholders own, against 236.7% for Gerresheimer.

  • GXI.DE

    Which costs less for the profit it is expected to make?

    Gerresheimer costs less for the profit it is expected to make: 13.5× its forward earnings, against 17.3×.

  • Which pays more in dividends?

    Alcon pays 0.45% a year in dividends for what a share costs, where Gerresheimer pays none.

  • ALC.SW

    Which do analysts rate higher?

    Analysts are warmer on Alcon: Buy, against Hold for Gerresheimer.

  • GXI.DE

    Which is in the stronger price trend?

    Gerresheimer's price is in the stronger trend: 13.7% above its 200-day average, against 7.2% above.

What each company does

ALC.SWAlcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.

Reports results on 23 February 2027

GXI.DEGerresheimer

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally.

Reports results on 25 November 2026

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.